Navigation Links
New polysaccharide may help combat multidrug resistance in cancer

In a recent study published in the Journal of Biological Chemistry, scientists report that a molecule previously thought to play a purely structural and inert role in cells is actually involved in multidrug resistance in cancer. Using antagonists for this molecule, the researchers were able to sensitize drug resistant breast cancer cells to chemotherapeutic drug treatment.

The research appears as the "Paper of the Week" in the May 27 issue of the Journal of Biological Chemistry, an American Society for Biochemistry and Molecular Biology journal.

Multidrug resistance is very common in most types of cancers, making it one of the leading problems in cancer therapy. It is often caused by an increase in the cell's production of proteins that transport drugs out of the cell, preventing the drugs from combating cancer.

Previously, Dr. Bryan P. Toole and his coworkers, Drs. Suniti Misra and Shibnath Ghatak, of the Medical University of South Carolina noticed that small pieces, or oligomers, of a polysaccharide called hyaluronan were able to sensitize drug-resistant breast cancer cells to several different chemotherapeutic drugs. He believed that the polysaccharide oligomers were binding to a receptor for hyaluronan (called CD44) and preventing it from initiating a signaling cascade that would result in drug resistance.

"It is very surprising that hyaluronan is involved in drug resistance," admits Dr. Toole. "Most scientists think of hyaluronan as a structural and inert molecule. In adult tissues it plays two roles. First, it assists in tissue hydration and in biophysical properties such as resilience. Second, it forms a template to which matrix proteins attach and form important extracellular structural complexes."

Hyaluronan also accumulates around the outside of cells during disease processes such as early atherogenesis, persistent inflammation, and cancer. In recent years, however, hyaluronan has also been shown to induce signaling
'"/>

Source:American Society for Biochemistry and Molecular Biology


Page: 1 2

Related biology news :

1. Molecular machine may lead to new drugs to combat human diseases
2. A bacterial genome reveals new targets to combat infectious disease
3. Light therapy may combat fungal infections, new evidence suggests
4. AIDS expert says global strategy needed to combat feminization of HIV/AIDS
5. Researcher at UGA College of Veterinary Medicine identifies new way of combating viral diseases
6. Storing carbon to combat global warming may cause other environmental problems, study suggests
7. New U. of Colorado at Boulder flu chip may help combat future epidemics, pandemics
8. Asleep in the deep: Model helps assess ocean-injection strategy for combating greenhouse effect
9. Pair of studies offer new clues to combat antibiotic resistance
10. Team discovers possible universal strategy to combat addiction
11. Retinol for combating leukemia cells

Post Your Comments:
(Date:11/30/2009)...gh team overcame a major hurdle plaguing the devel...ead to more efficient catalysts used to produce hy...archers reported Nov. 29 in Nature Materials the... in metallic nanoparticles, the vaunted next-gener...reme heat. , Gtz Veser, an associate professor a...
(Date:11/30/2009)...LSU Health Sciences Center New Orleans School of P...itute of Child Health and Human Development (NICHD...men,s Hospital, and Harvard Medical School, have f...servings of sugar- sweetened cola a week prior to ...k of developing diabetes during pregnancy. Liwei C...
(Date:11/30/2009)...erimental Biology are pleased to announce that Dr...e Scientifique (CNRS) in the Universit de Nice-Sop...utstanding Paper Prize. ,The prize is awarded in r...tended to encourage young scientists, says Hans H... ,we truly appreciate when authors submit their ve...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4WellPoint Announces Appearance at Upcoming Conference 56469 1WellPoint Announces Appearance at Upcoming Conference 56469 2Trubion Pharmaceuticals Inc to Present at the Morgan Stanley Global Healthcare Conference 13910 1Trubion Pharmaceuticals Inc to Present at the Morgan Stanley Global Healthcare Conference 13910 2Motivation May Be at Root of ADHD 56464 1Motivation May Be at Root of ADHD 56464 2Motivation May Be at Root of ADHD 56464 3
..., just think back to about 110 million years ago w...arger animals, a behemoth called Sauroposeidon pro.... Now, a new study led by the University of Florid...e to 48 degrees Celsius. , That is a 118-degree ...t living creatures can get before the proteins in ...
...glacier field in Canada,s High Arctic may help res... life and provide insights for future exploration ...versity of Calgary,s Arctic Institute of North Ame...ewing spring on the surface of an ice field not fa...scovered by Institute Executive Director Dr. Benoi...
...uly 5 in an advanced, online edition of the Procee...d a significant enhancement of the treatment of me... showed the new hybrid compound remained in circul...e drug was cleared in a matter of minutes. , "Alt...cer, these new findings could have broad applicati...
Other Biology News:Large dinosaurs were extremely hot in their day, UF study finds 2Large dinosaurs were extremely hot in their day, UF study finds 3Arctic expedition will investigate alien-like glacier 2Researchers unveil strategy for creating actively-programmed anti-cancer molecules 2Researchers unveil strategy for creating actively-programmed anti-cancer molecules 3
(Date:12/1/2009)... Dec. 1 Aethlon Medical,...hat it will present at the LD MICRO Conference on ...he Luxe Hotel in Los Angeles. Aethlon Medical,s Ch...porate overview and will provide an update on the ...the Hemopurifier®, a first-in-class artificia...
(Date:12/1/2009)...L, Dec. 1 /PRNewswire-FirstCall/ - BioSpec Global ...T), announced today that the company has contracte...ada for the manufacturing of the TOG,S 3000 and 90..., "We have seen the disastrous results of food con...ged salads in the past" said Don Saunders Presiden...
(Date:12/1/2009)...iac now provides services to three out of top five... Rochester, NY (PRWEB) December 1, 2009...n advanced cardiac core lab services and QT analys... company has selected iCardiac as a preferred vend...e Highly Automated QT(sm) and Dynamic QT beat-to-b...
(Date:11/30/2009)...SSIA, Pa., Nov. 30 Cadient Intera... interactive marketing services and solutions for ...h of its HATCH Consulting services group ( w...egic experts across a range of emerging areas of f... team is committed to guiding companies and brands...
Breaking Biology Technology:Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3
...RICK, Md., Feb. 9 ImQuest Life Sciences today pre...lopment of their small molecule inhibitor of HIV-1...al. The presentation highlighted the advanced deve...bitor, IQP-0410. The pyrimidinediones are highly p...sm of action which includes targeting virus entry ...
...opment activities are intended to support regulato...er blockers , , SAN DIEGO, CA, February 9, 2009 ... focused on using proprietary technologies to disc...food, beverage, and ingredient supply industries, ...activities for S0812 and additional new bitter blo...
...EYKJAVIK, Iceland, February 9 In a paper,publishe...CGN ) and academic,colleagues from four continents...en inflammation and heart disease. Through a genom...E team discovered several common single-letter,var... that increase levels of,eosinophils in the bloods...
Other Biology Technology:ImQuest Presents IND-Enabling Safety Pharmacology and Pharmacokinetic Data for the Therapeutic HIV Compound IQP-0410 at Conference on Retroviruses and Opportunistic Infections 2SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 2SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 3SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW BITTER BLOCKERS 4Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack 2Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack 3Multinational deCODE Study Identifies New Link Between Inflammation and Heart Attack 4
...lly designed to target and display recombinant pro...Displayed proteins can be analyzed for their abili...1 uses the a-agglutinin yeast adhesion receptor wh...ay recombinant protein on the surface of S. cerevi...
15(S)-15-methyl Prostaglandin F2alpha from Cayman Chemical
...yrene divinylbenzene beads for size exclusion chro...ons that require organic eluents. The beads are co...rachloride, dimethylformamide, ketones, aromatics,...thylene, tetrahydrofuran, and trichlorobenzene. Th...
... A BALB/c mouse was immunized with Glutathione-S-...d Storage: Store vial at -20 C prior to opening. ... extended storage. Avoid cycles of freezing and t...r after standing at room temperature. Family: ...
Biology Products: